Skip to main content

ADAGE CAPITAL PARTNERS GP, L.L.C.

Position in NVO — Novo Nordisk A S

CIK 1165408 Boston, MA

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$42,073,821
+$17,905,821 QoQ
Shares Held
877,635
+84.8% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#59
of 1,348 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

ADAGE CAPITAL PARTNERS GP, L.L.C. holds $2,791,248,361 across 11 Drug Manufacturers - General names. NVO ranks #9 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVO

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $42,073,821 877,635
2025-12-31 $24,168,000 475,000
2024-09-30 $94,556,463 794,125
2024-06-30 $108,393,187 759,375
2024-03-31 $105,008,858 817,826
2023-12-31 $84,248,852 814,392
2023-09-30 $123,551,447 1,358,604
2023-06-30 $93,314,090 576,618
2023-03-31 $41,027,724 257,809
2022-12-31 $47,935,533 354,186
2022-09-30 $38,683,340 388,270
2022-06-30 $55,581,841 498,805
2022-03-31 $62,076,950 559,000
2021-12-31 $58,800,000 525,000
2020-09-30 $6,943,000 100,000
2020-06-30 $13,096,000 200,000
2020-03-31 $24,080,000 400,000